Kening Li

878 total citations
9 papers, 282 citations indexed

About

Kening Li is a scholar working on Infectious Diseases, Neurology and Oncology. According to data from OpenAlex, Kening Li has authored 9 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Neurology and 3 papers in Oncology. Recurrent topics in Kening Li's work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Kening Li is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Kening Li collaborates with scholars based in China and Nigeria. Kening Li's co-authors include Lingxiang Wu, Wei Wu, Bin Huang, Mengyan Zhu, Qianghu Wang, Yun Cai, Bakwatanisa Bosco, Xinyi Xia, Zhihua Wang and Lu Li and has published in prestigious journals such as Nature Communications, Leukemia and Briefings in Bioinformatics.

In The Last Decade

Kening Li

8 papers receiving 278 citations

Peers

Countries citing papers authored by Kening Li

Since Specialization

Citations

This map shows the geographic impact of Kening Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kening Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kening Li more than expected).

Fields of papers citing papers by Kening Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kening Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kening Li. The network helps show where Kening Li may publish in the future.

Co-authorship network of co-authors of Kening Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kening Li. A scholar is included among the top collaborators of Kening Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kening Li. Kening Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	SCANER: robust and sensitive identification of malignant cells from the scRNA-seq profiled tumor ecosystem 2025 ·Briefings in Bioinformatics ·Peng Xia, Wei Wu, (unknown), Bin Huang, Min Wu, Zihan Lin, Mengyan Zhu, Miao Yu, Ying Qu, Kening Li, (unknown), Ruohan Zhang, Qianghu Wang	0
2	The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin’s lymphoma tumor growth by promoting apoptosis and autophagy 2023 ·Cell Communication and Signaling ·Yan Lv, Yuxin Du, Kening Li, Xiao Ma, Juan Wang, (unknown), (unknown), Yue Teng, (unknown), Rong Ma, Jianqiu Wu, Jian Wu, Jifeng Feng	9
3	Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia 2022 ·Leukemia ·Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qianghu Wang, Ming Hong, Sixuan Qian	57
4	Detection and Localization of Solid Tumors Utilizing the Cancer-Type-Specific Mutational Signatures 2022 ·Frontiers in Bioengineering and Biotechnology ·Ziyu Wang, Tingting Zhang, Wei Wu, Lingxiang Wu, Jie Li, (unknown), Yuan Liang, Yan Li, Pengping Li, Kening Li, Wei Wang, Renhua Guo, Qianghu Wang	2
5	High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis 2021 ·Frontiers in Oncology ·Qianqian Wang, (unknown), Tianyu Qu, (unknown), Lingxiang Wu, Kening Li, Ziyu Wang, Mengyan Zhu, Bin Huang, Wei Wu, Min Wu, Rong Ding, Zhihong Zhang, (unknown), Qianghu Wang, Xinyi Xia, Pengping Li, Zhi Zhang, Renhua Guo	16
6	Laboratory Testing Implications of Risk-Stratification and Management of COVID-19 Patients 2021 ·Frontiers in Medicine ·(unknown), Ziyu Wang, Wei Wu, (unknown), Lingxiang Wu, Jie Li, (unknown), Huiling Sun, Youli Wang, (unknown), (unknown), Ruisheng Zhang, (unknown), Qianghu Wang, Kening Li, Xinyi Xia, Pengping Li, Shukui Wang	3
7	Implications of liver injury in risk-stratification and management of patients with COVID-19 2021 ·Hepatology International ·Jiaofang Shao, Yuan Liang, Yan Li, Rong Ding, Mengyan Zhu, Wenhua You, Ziyu Wang, Bin Huang, (unknown), Tingting Zhang, Kening Li, Wei Wu, Lingxiang Wu, Qianghu Wang, Xinyi Xia, Shukui Wang, Ling Lü	15
8	Sex-based clinical and immunological differences in COVID-19 2021 ·BMC Infectious Diseases ·Bin Huang, Yun Cai, Ning Li, Kening Li, Zhihua Wang, Lu Li, Lingxiang Wu, Mengyan Zhu, Jie Li, Ziyu Wang, Min Wu, Wanlin Li, Wei Wu, Lishen Zhang, Xinyi Xia, Shukui Wang, Hongshan Chen, Qianghu Wang	26
9	Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 2020 ·Nature Communications ·Kening Li, Bin Huang, Min Wu, Aifang Zhong, Lu Li, Yun Cai, Zhihua Wang, Lingxiang Wu, Mengyan Zhu, Jie Li, Ziyu Wang, Wei Wu, Wanlin Li, Bakwatanisa Bosco, Zhenhua Gan, Qinghua Qiao, Jian Wu, Qianghu Wang, Shukui Wang, Xinyi Xia	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact